In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Example Input: Federal Health Care Board Act of 2007 - Establishes the Federal Health Care Board as an independent agency in the executive branch.

Requires the Board to: (1) ensure that Americans have access to health insurance and are provided certain basic facts about health care services prior to receiving care; (2) ensure that providers are delivering safe, evidence-based, high quality care and are transparent about pricing through disclosure of actual costs; (3) demand transparency for disclosure of actual costs and pricing from providers and payers through an information clearinghouse; (4) establish a national standard for a basic health insurance plan (including a basic minimum policy and the regional cost for such policy), a national protocol and standard for secure, universal, and individual electronic medical records, a national standard for public health services (including safety net providers), loan forgiveness and scholarship programs for health care providers who serve in underserved areas, and model dispute resolution procedures for malpractice claims that states may adopt; and (5) monitor progress toward those objectives.

Directs the Board's Board of Governors to establish 12 regions of the United States. Establishes in each region a Regional Board, based in a major city, to provide the Board of Governors with considerations that are relevant to their region's population.
Example Output: A bill to provide for the establishment of the Federal Health Care Board.

Example Input: Clear Creek County, Colorado, Public Lands Transfer Act of 1993 - Directs the Secretary of the Interior to transfer certain public lands in Clear Creek County, Colorado, to the Secretary of Agriculture, the State of Colorado, and certain local governments (Clear Creek County and the towns of Silver Plume and Georgetown).
Modifies the boundaries of the Arapaho National Forest, Colorado, to include certain lands conveyed to the Secretary of Agriculture.
Withdraws the public lands transferred to Colorado and the local governments from U.S. mining and mineral leasing laws.
Requires the consent of the Secretary before the grantee or its successor can transfer the title of such conveyed lands. Makes the grantee liable to the Secretary for the fair market value of such conveyed lands if such lands are devoted to a use inconsistent with limitations under this Act or transferred to another party.
Relieves: (1) the Secretary from being required to inspect any public lands described in this Act or to inform Clear Creek County or any member of the public regarding the condition of such lands with respect to the presence or absence of hazardous substances or otherwise; and (2) the United States from liability regarding hazardous wastes or substances placed on such lands after their transfer to the ownership of another party.
Example Output: Clear Creek County, Colorado, Public Lands Transfer Act of 1993

Example Input: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 This bill requires the Government Accountability Office (GAO) to study whether generic versions of certain complex drugs or certain biological drugs face significantly different challenges in meeting the approval standards of the Food and Drug Administration (FDA) than generic versions of small-molecule drugs. (Complex drugs and biological drugs can be composed of large molecules that are more difficult to fully characterize than small molecules, so it can be more difficult to demonstrate that generic versions of these drugs are the same as the brand name versions.) If the GAO determines that these generic drugs face significantly different challenges, then the GAO must also determine: (1) the evidence that should be required to demonstrate that one of these generic drugs is sufficiently similar to the brand name drug in safety, composition, and activity; (2) whether the Federal Food, Drug, and Cosmetic Act should be amended to address the approval of these generic drugs; and (3) whether the FDA should develop a policy document on the evidence that is necessary to obtain approval of these generic drugs.
Example Output:
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015